JoelGregoryWinnerMD

PubMed

• 27 citations
  Analytical validation of a psychiatric pharmacogenomic test.
  Michael R. Jablonski, King Nina, Wang Yongbao, Joel G. Winner, Lucas R Watterson, Gunselman Sandra, Bryan Dechairo> ;Personalized Medicine. 2018 May 1
• 47 citations
  Clinical Utility of Combinatorial Pharmacogenomics-Guided Antidepressant Therapy: Evidence from Three Clinical Studies.
  C Anthony Altar, Joseph M Carhart, Josiah D. Allen, Daniel K. Hall-Flavin, Joel G. Winner, Bryan Dechairo> ;Molecular Neuropsychiatry. 2015 Jul 31
• 3 citations
  Use of combinatorial pharmacogenomic testing in two cases from community psychiatry
  Eve S. Fields, Raymond A Lorenz, Joel G Winner> ;Pharmacogenomics and Personalized Medicine. 2016 Aug 16
• 13 citations
  Combinatorial Versus Individual Gene Pharmacogenomic Testing in Mental Health: A Perspective on Context and Implications on Clinical Utility.
  Joel G. Winner, Bryan Dechairo> ;The Yale Journal of Biology and Medicine. 2015 Nov 24
• 68 citations
  Combinatorial pharmacogenomic guidance for psychiatric medications reduces overall pharmacy costs in a 1 year prospective evaluation.
  Joel G. Winner, Joseph M Carhart, C Anthony Altar, Seth Goldfarb, Josiah D. Allen, Gabriela Lavezzari, Kelly K Parsons, Andrew G Marshak, Susan Garavaglia, Bryan Dechairo> ;Current Medical Research and Opinion. 2015 Jun 18
• 13 citations
  The clinical validity and utility of combinatorial pharmacogenomics: Enhancing patient outcomes.
  Joachim Benitez, Michael R. Jablonski, Josiah D. Allen, Joel G. Winner> ;Applied & Translational Genomics. 2015 Jun 1
• 74 citations
  Clinical validity: Combinatorial pharmacogenomics predicts antidepressant responses and healthcare utilizations better than single gene phenotypes
  C A Altar, Joseph M Carhart, Josiah D. Allen, Daniel K. Hall-Flavin, Bryan Dechairo, Joel G. Winner> ;The Pharmacogenomics Journal. 2015 Feb 17
• 131 citations
  A prospective, randomized, double-blind study assessing the clinical impact of integrated pharmacogenomic testing for major depressive disorder.
  Joel G. Winner, Joseph M Carhart, C Anthony Altar, Josiah D. Allen, Bryan Dechairo> ;Discovery Medicine. 2013 Nov 1
• 139 citations
  Utility of integrated pharmacogenomic testing to support the treatment of major depressive disorder in a psychiatric outpatient setting.
  Daniel K. Hall-Flavin, Joel G. Winner, Josiah D. Allen, Joseph M Carhart, Brian D. Proctor, Karen Snyder, Maureen S. Drews, Linda L. Eisterhold, Jennifer R. Geske, Dav...> ;Pharmacogenetics and Genomics. 2013 Oct 1
• 92 citations
  Psychiatric pharmacogenomics predicts health resource utilization of outpatients with anxiety and depression.
  Joel G. Winner, Josiah D. Allen, C Anthony Altar, A Spahic-Mihajlovic> ;Translational Psychiatry. 2013 Mar 19
• 133 citations
  Using a pharmacogenomic algorithm to guide the treatment of depression.
  Daniel K. Hall-Flavin, Joel G. Winner, Josiah D. Allen, J J Jordan, R S Nesheim, Karen Snyder, Maureen S. Drews, L L Eisterhold, Joanna M. Biernacka, David A. Mrazek> ;Translational Psychiatry. 2012 Oct 16
• 19 citations
  Training in psychiatric genomics during residency: a new challenge.
  Joel G. Winner, Deborah A. Goebert, Courtenay Matsu, David A. Mrazek> ;Academic Psychiatry. 2010 Mar 1
• Join now to see all